APA (7th ed.) Citation

Ramchandren, R., Advani, R. H., Ansell, S. M., Bartlett, N. L., Chen, R., Connors, J. M., . . . Straus, D. J. (2019). Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma. Clinical cancer research, 25(6), 1718-1726. https://doi.org/10.1158/1078-0432.CCR-18-2435

Chicago Style (17th ed.) Citation

Ramchandren, Radhakrishnan, et al. "Brentuximab Vedotin Plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma." Clinical Cancer Research 25, no. 6 (2019): 1718-1726. https://doi.org/10.1158/1078-0432.CCR-18-2435.

MLA (9th ed.) Citation

Ramchandren, Radhakrishnan, et al. "Brentuximab Vedotin Plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma." Clinical Cancer Research, vol. 25, no. 6, 2019, pp. 1718-1726, https://doi.org/10.1158/1078-0432.CCR-18-2435.